WATCH: Purdue superfan inspires team's unlikely win over Ohio State
Tyler Trent, 20, a Purdue sophomore, has terminal bone cancer and was invited by the team to address the players in the locker room. (Source: ABC News: Health)
Source: ABC News: Health - October 22, 2018 Category: Consumer Health News Tags: GMA Source Type: news

New clinical trials seek treatments for canine cancers, may offer clues on human cancers
(Tufts University) Two studies into deadly cancers in dogs are now underway, offered through the newly formed Clinical Trials Office at Cummings Veterinary Medical Center at Tufts University. Dogs with spontaneous osteosarcoma, as well as dogs with mast cell tumors and solid tumors, may be eligible for enrollment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 11, 2018 Category: Cancer & Oncology Source Type: news

'My jaw was reconstructed from my shoulder'
When Jen Taylor was diagnosed with bone cancer, she underwent 16 hours of surgery. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 28, 2018 Category: Consumer Health News Source Type: news

Brave eight-year-old boy battles second bout of brain cancer since he was just two
Jaxon Dugger, eight, from Hollis, Oklahoma, was fist diagnosed with Ewing sarcoma when he was just two years old. Three months after being declared cancer-free, his tumor returned. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2018 Category: Consumer Health News Source Type: news

Dancer, 12, who lost leg to rare bone cancer undergoes operation to turn her ankle into a KNEE
Delaney Unger, 12, from Selden, New York, was diagnosed with osteosarcoma, a type of bone cancer, in December 2016 and was told that part of her leg would need to be amputated. (Source: the Mail online | Health)
Source: the Mail online | Health - September 10, 2018 Category: Consumer Health News Source Type: news

Children's bone cancers could remain hidden for years before diagnosis
(Wellcome Trust Sanger Institute) Scientists have discovered that some childhood bone cancers start growing years before they are diagnosed. Researchers at the Wellcome Sanger Institute, UK and Hospital for Sick Children (SickKids), Canada discovered large-scale genetic rearrangements in Ewing Sarcomas and other children's cancers, and showed these can take years to form. The study in Science will help unravel causes of childhood cancers and could help find ways to diagnose and treat these cancers earlier in the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 30, 2018 Category: Cancer & Oncology Source Type: news

Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
Sarcomas are cancers of the bone and soft tissue often defined by gene fusions. Ewing sarcoma involves fusions between EWSR1, a gene encoding an RNA binding protein, and E26 transformation-specific (ETS) transcription factors. We explored how and when EWSR1-ETS fusions arise by studying the whole genomes of Ewing sarcomas. In 52 of 124 (42%) of tumors, the fusion gene arises by a sudden burst of complex, loop-like rearrangements, a process called chromoplexy, rather than by simple reciprocal translocations. These loops always contained the disease-defining fusion at the center, but they disrupted multiple additional genes....
Source: ScienceNOW - August 30, 2018 Category: Science Authors: Anderson, N. D., de Borja, R., Young, M. D., Fuligni, F., Rosic, A., Roberts, N. D., Hajjar, S., Layeghifard, M., Novokmet, A., Kowalski, P. E., Anaka, M., Davidson, S., Zarrei, M., Id Said, B., Schreiner, L. C., Marchand, R., Sitter, J., Gokgoz, N., Brun Tags: Genetics, Medicine, Diseases, Online Only r-articles Source Type: news

Modern myths about cancer – from ‘chemicals’ in food to wifi
The idea that lifestyle changes have made the disease more common is a gross exaggeration – but increasingly prevalent. We separate fact from fictionCancer is not up there withthe most likely explanations for what caused the mass extinction 66m years ago of the T rex and the triceratops. That said, at leastone species of dinosaur suffered from blood-vessel tumours – anda 1.7m-year-old toe with bone cancer was discovered in 2016 at a South African world heritage site.Cancer may have been more common in ancient times than we will ever know, because fossilisation will have obliterated most evidence of the disease....
Source: Guardian Unlimited Science - August 20, 2018 Category: Science Authors: Naomi Elster Tags: Cancer research Health & wellbeing Society Medical research Science Life and style Source Type: news

MGH team defines the mechanisms of action of key genetic abnormality in Ewing sarcoma
(Massachusetts General Hospital) A Massachusetts General Hospital research team has used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma -- the second most common bone cancer in children and young adults -- unleashes tumor growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 2, 2018 Category: Cancer & Oncology Source Type: news

Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Cells respond to DNA damage by activating complex signaling networks that decide cell fate, promoting not only DNA damage repair and survival but also cell death. We have developed a multiscale computational model that quantitatively links chemotherapy-induced DNA damage response signaling to cell fate. The computational model was trained and calibrated on extensive data from U2OS osteosarcoma cells, including the cell cycle distribution of the initial cell population, signaling data measured by Western blotting, and cell fate data in response to chemotherapy treatment measured by time-lapse microscopy. The resulting mecha...
Source: Signal Transduction Knowledge Environment - July 24, 2018 Category: Science Authors: Alkan, O., Schoeberl, B., Shah, M., Koshkaryev, A., Heinemann, T., Drummond, D. C., Yaffe, M. B., Raue, A. Tags: STKE Research Articles Source Type: news

Medical News Today: What is osteosarcoma?
Osteosarcoma is a type of bone cancer that often affects the shinbone, thighbone, or upper arm. Doctors are currently unsure of the causes, but genetics may play a role. Treatment includes chemotherapy and surgery. The outlook depends on if and how far cancerous cells have spread. Learn more about osteosarcoma here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 23, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Emma Neagu had her foot fitted backwards after having bone cancer
Emma Neagu, now 14, from Toronto, was diagnosed with a form of bone cancer known as osteosarcoma in 2016. The teen endured nine months of grueling chemotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - July 23, 2018 Category: Consumer Health News Source Type: news

Gymnast, 14, chose to have her foot removed and refitted backwards after developing bone cancer
Emma Neagu, now 14, from Toronto, was diagnosed with a form of bone cancer known as osteosarcoma in 2016. The teen endured nine months of grueling chemotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - July 23, 2018 Category: Consumer Health News Source Type: news

Products of omega-3 fatty acid metabolism may have anticancer effects, study shows
(University of Illinois at Urbana-Champaign) A class of molecules formed when the body metabolizes omega-3 fatty acids could inhibit cancer's growth and spread, University of Illinois researchers report in a new study in mice. In mice with tumors of osteosarcoma - a bone cancer that is notoriously painful and difficult to treat -- endocannabinoids slowed the growth of tumors and blood vessels, inhibited the cancer cells from migrating and caused cancer cell death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Olathe biotech moves dog cancer treatment closer to market
A Kansas City-area animal health company is ramping up its efforts to take its cancer immunotherapy treatment to market. Elias Animal Health, a subsidiary of Olathe-based TVAX Biomedical Inc., applied for a conditional licensure of its treatment for dogs with bone cancer through the U.S. Department of Agriculture’s Center for Veterinary Biologics. Elias recently completed preliminary studies of its osteosarcoma treatment and will enroll for a pivotal study as the next step. On Thursday, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 14, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Genetic discovery will help clinicians identify aggressive versus benign bone tumors
(Wellcome Trust Sanger Institute) The first genetic marker for the bone tumor, osteoblastoma, has been discovered by scientists at the Wellcome Sanger Institute and their collaborators. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results, published in Nature Communications, will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2018 Category: Cancer & Oncology Source Type: news

Bone cancer symptoms: Watch out for these less common arthritis-like symptoms
BONE cancer symptoms include aching within the bones, which can be mistaken for arthritis. However, there are also three other symptoms, according to the NHS. (Source: Daily Express - Health)
Source: Daily Express - Health - May 26, 2018 Category: Consumer Health News Source Type: news

Medical News Today: What could cause bone pain?
People may feel aches or pains in their bones for a variety of reasons. Many people worry when they experience bone pain because it can be a sign of bone cancer. For this reason, prompt diagnosis is essential. Learn more about bone pain symptoms, the signs of cancer, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2018 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

Innovative vaccine offers canine cancer patients a shot at a longer, happier life
(University of Pennsylvania) Nicola Mason of the School of Veterinary Medicine is leading a multi-institutional clinical trial evaluating an immunotherapy approach to treat dogs with osteosarcoma, a cancer of the bone. A new $775,000 grant from the Morris Animal Foundation will help her build on her past successes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

Girl has leg reattached backwards after cancer surgery
Amelia Eldred who lost her limb to bone cancer has rare procedure which could allow her to dance again. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 25, 2018 Category: Consumer Health News Source Type: news

New connections: Ewings sarcomas driver is its Achilles heel
Several studies identify drug combinations that target or exploit the EWS-FLI1 fusion protein to kill Ewing’s sarcoma cells. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - April 24, 2018 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

The inspirational reason girl, 7, who lost her leg to cancer had her limb attached BACKWARDS
Amelia Eldred, 7, from Tamworth, had her left leg amputated because of a rare form of bone cancer, but her lower leg has been reattached so her ankle can act as a knee when she gets a prosthetic leg. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2018 Category: Consumer Health News Source Type: news

Morris Animal Foundation awards $775K to test osteosarcoma immunotherapy vaccine in dogs
(Morris Animal Foundation) Morris Animal Foundation has awarded a $775,000 grant to the University of Pennsylvania to test a vaccine that could improve longevity and quality of life for dogs with the deadly bone tumor, osteosarcoma. The research team will conduct clinical trials to evaluate a novel immunotherapy treatment which combines a molecule expressed by cancer cells with a modified live form of the bacteria Listeria monocytogenes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2018 Category: Biology Source Type: news

Pregnant woman, 29, diagnosed with terminal cancer after scan 17 weeks into her first pregnancy
Laura King, a nursery director from Surrey, beat breast cancer in 2017. After the all-clear, she and her husband decided to start a family. Weeks later, she was diagnosed with secondary bone cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 13, 2018 Category: Consumer Health News Source Type: news

A potential new therapeutic target for Ewing sarcoma
(IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL researchers correlate EphA2 membrane receptor with the metastatic capacity of tumors in Ewing sarcoma.Ewing sarcoma is the second most frequent bone cancer among children and adolescents, and it is characterized by its aggressiveness and tendency to metastasize.Researchers are currently working on nanoengineering a molecule capable of blocking EphA2 and deliver drugs in a targeted manner.Research was possible thanks to the backing of Alba P é rez Foundation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2018 Category: Cancer & Oncology Source Type: news

Greehey Institute team finds link between BRCA1 and Ewing sarcoma
(University of Texas Health Science Center at San Antonio) Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma. Their findings were made public March 7 online in the journal Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 7, 2018 Category: Cancer & Oncology Source Type: news

PET imaging could help personalize cancer treatment
Researchers have developed a same-day, noninvasive PET imaging approach to...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT predicts outcomes in pediatric osteosarcoma Artificial intelligence guides lower PET tracer dose PET tracer could better assess lung ailments SNMMI posts criteria for somatostatin receptor PET Deep learning analyzes PET for signs of dementia (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 2, 2018 Category: Radiology Source Type: news

Gemcitabine Plus Sirolimus for Osteosarcoma Gemcitabine Plus Sirolimus for Osteosarcoma
The combination of gemcitabine and sirolimus may be a safe and effective option for patients with relapsed unresectable osteosarcoma.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Scientists tackle the aberrant epigenetic programming underlying childhood cancers
(Write Science Right) Researchers at UFRGS and the US NIH have targeted proteins that regulate chromatin in Ewing sarcoma cells, hindering malignant tumor growth. They induced chromatic relaxation by treating the cells with histone deacetylase inhibitors, reducing expression of the EWSR1-FLI-1 oncogene and other pluripotency/cell viability genes, while impairing sarcoma cell survival and growth. Decreased survival of stem-like cancer cells and re-expression of a neuronal differentiation marker were also observed. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2018 Category: International Medicine & Public Health Source Type: news

Marijuana laws in New Jersey are loosening restrictions in the wake of a young boy’s tragic death to rare cancer
(Natural News) Phil Murphy, New Jersey’s governor, has recently signed “an executive order for broader medical marijuana access.” Jake Honig, a seven-year-old boy who died last January due to a rare bone cancer, seems to have moved the governor to make this particular decision. Jake, who received the nickname “Jake the Tank” because of the... (Source: NaturalNews.com)
Source: NaturalNews.com - February 13, 2018 Category: Consumer Health News Source Type: news

Unique research approach finds FDA-approved drug shuts down Ewing sarcoma cells in lab
(Georgetown University Medical Center) Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 30, 2018 Category: Cancer & Oncology Source Type: news

Alex Huang, M.D., Ph.D., receives $450,000 from Pediatric Cancer Research Foundation
(Case Western Reserve University) Leading cancer researcher, Alex Huang M.D., Ph.D., has received a $450,000 Basic Science grant from Pediatric Cancer Research Foundation to study targeted approaches for effectively eliminating metastatic osteosarcoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 25, 2018 Category: International Medicine & Public Health Source Type: news

Cancer researchers hit a bullseye with new drug target for Ewing sarcoma
(Boston Children's Hospital) Kimberly Stegmaier of Dana-Farber/Boston Children's Cancer and Blood Disorders Center and collaborators have found that Ewing sarcoma cells die if an enzyme called CDK12 is knocked out genetically or chemically inhibited. What's more, when a CDK12 inhibitor is combined with another drug, called a PARP inhibitor, the two drugs double down to deliver a lethal punch to Ewing sarcoma cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 25, 2018 Category: Biology Source Type: news

FDG-PET/CT predicts outcomes in pediatric osteosarcoma
The best way to predict a good outcome for pediatric patients with osteosarcoma...Read more on AuntMinnie.comRelated Reading: UC Davis group reports progress on total-body PET/CT FDA issues guidance on lowering pediatric x-ray dose FDG-PET, DWI-MRI help predict osteosarcoma chemo response FDG-PET/CT a good option for imaging pediatric osteosarcoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 19, 2018 Category: Radiology Source Type: news

Promising Experimental Drug Treating Dogs With Cancer
NORTH GRAFTON (CBS) – When it comes to cancer research, dogs just might be the key to unlock vital clues needed to find a cure. Veterinarians in central Massachusetts are excited about some recent results and it’s also making for some extremely thankful pet owners. “They gave me my best friend back and they gave him more time, quality time,” said Edward Sloan, whose dog, Dozer, a 7-year-old bull mastiff, became sick last fall. “All of sudden he went blind, overnight,” Sloan said. “He was scared.  He was sad.” Dozer had cancer. Dozer, a 7-year-old bull mastiff, is be...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 13, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Cancer Dr. Mallika Marshall Source Type: news

Molecular imaging technique identifies lung nodules for resection in osteosarcoma patient
(SPIE--International Society for Optics and Photonics) Utility of near-infrared molecular imaging in a patient undergoing pulmonary metastasectomy for osteosarcoma has been reported by researchers from Perelman School of Medicine at the University of Pennsylvania and Purdue University. The work is reported in an article in the Journal of Biomedical Optics published this week by SPIE, the international society for optics and photonics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 5, 2018 Category: International Medicine & Public Health Source Type: news

Aratana nears approval for canine cancer vaccine
Aratana Therapeutics Inc.'s cancer immunotherapy drug for dogs gained a conditional license from the U.S. Department of Agriculture, the company announced Wednesday. To gain full licensure, Aratana (Nasdaq; PETX) will start another field study in early 2018. The vaccine initially will be available for purchase at 12 veterinary oncology practices participating in the study. It's designed to treat dogs with bone cancer after the tumor is surgically removed. It works using listeria, a type of bacteria,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 21, 2017 Category: American Health Authors: Elise Reuter Source Type: news

Aratana nears approval for canine cancer vaccine
Aratana Therapeutics Inc.'s cancer immunotherapy drug for dogs gained a conditional license from the U.S. Department of Agriculture, the company announced Wednesday. To gain full licensure, Aratana (Nasdaq; PETX) will start another field study in early 2018. The vaccine initially will be available for purchase at 12 veterinary oncology practices participating in the study. It's designed to treat dogs with bone cancer after the tumor is surgically removed. It works using listeria, a type of bacteria,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 21, 2017 Category: Biotechnology Authors: Elise Reuter Source Type: news

Aratana nears approval for canine cancer vaccine
Aratana Therapeutics Inc.'s cancer immunotherapy drug for dogs gained a conditional license from the U.S. Department of Agriculture, the company announced Wednesday. To gain full licensure, Aratana (Nasdaq; PETX) will start another field study in early 2018. The vaccine initially will be available for purchase at 12 veterinary oncology practices participating in the study. It's designed to treat dogs with bone cancer after the tumor is surgically removed. It works using listeria, a type of bacteria,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 21, 2017 Category: Health Management Authors: Elise Reuter Source Type: news

N.M. Paramedic Helps Young Cancer Patient With His 'Bucket List'
RIO RANCHO, N.M. (KRQE) –They met only once, but a strong bond ties a local paramedic to her former patient. Now, she’s hoping to help grant a big wish for a child battling cancer. Paramedic Jennifer Saiz is a cancer survivor but her patient is still in the fight. She says his joyful spirit touched her so much, she wanted to help check off an item on his bucket list. At the Dimas’ household, there are plenty of presents wrapped under the tree. But what’s on 10-year-old Elijah’s Christmas list can’t be tied with a bow. “Visit the Pokémon center in Japan, get Nickelodeon...
Source: JEMS Administration and Leadership - December 13, 2017 Category: Emergency Medicine Authors: Francesca Washington, KRQE Tags: News Videos Administration and Leadership Source Type: news

PharmaMar presents positive results from a Phase II study of PM1183 in Ewing's sarcoma
(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing ´ s sarcoma at the Connective Tissue Oncology Society ´ s (CTOS) International Congress that took place in Hawaii from the 8th to the 11th of November. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news

HKBU Chinese medicine scholars develop HKBU Chinese medicine scholars develop
(Hong Kong Baptist University) Chinese Medicine scholars at Hong Kong Baptist University (HKBU) have succeeded in developing a novel targeted delivery system for CRISPR/Cas9 to achieve therapeutic genome editing of VEGFA in osteosarcoma (OS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

With three products out, Aratana chases its fourth: a canine cancer drug
With its third FDA-approved drug on the market, Aratana Therapeutics is hunting its next product, a canine cancer immunotherapy treatment. The treatment, called AT-014, would be used to treat bone cancer, or osteosarcoma, in dogs. After a tumor is removed, a vaccine is used to prime the dog’s immune system to target any remaining cancer. Aratana (Nasdaq: PETX) expects to obtain conditional licensure for the treatment from the U.S . Department of Agriculture before the end of 2017, which would… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Two classes of GGAA-microsatellites in a Ewing sarcoma context
(Nationwide Children's Hospital) In a study published in PLOS ONE, researchers describe two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma. Ewing sarcoma is the second most common pediatric bone malignancy. It is initiated by chromosomal translocation t(11;22)(q24;q12), which creates the fusion protein and oncogenic driver EWS/FLI. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 1, 2017 Category: Cancer & Oncology Source Type: news

Just-in-time 3-D implants set to transform tumor surgery
(RMIT University) The project team will combine 3-D printing, robotic surgery and advanced manufacturing to create tailored implants for patients with bone cancer, dramatically improving patient and healthcare outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2017 Category: Cancer & Oncology Source Type: news

Three of the most deadly cancers get critical funding for research
Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer. Three scientists have received $1.3 million in critical funding from the Alliance for Cancer Gene Therapy (ACGT), the nation's only nonprofit dedicated exclusively to cell and gene therapies for cancer. (Source: World Pharma News)
Source: World Pharma News - October 18, 2017 Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news

Living With Cancer: Cancer Humor
Cracking up may be a better option than breaking down, or so three recent books by young people with cancer suggest. (Source: NYT Health)
Source: NYT Health - October 12, 2017 Category: Consumer Health News Authors: SUSAN GUBAR Tags: Breast Cancer Books and Literature Ewing's Sarcoma (Disease) Comedy and Humor Riggs, Nina (1977-2017) Harrison, Teva (1976- ) Ritvo, Max (1990-2016) Source Type: news

New drug hope for rare bone cancer patients
Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust. In the largest genomics study of chordoma to date, published today in Nature Communications, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors. (Source: World Pharma News)
Source: World Pharma News - October 12, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

New drug hope for rare bone cancer patients
(Wellcome Trust Sanger Institute) Patients with a rare bone cancer of the skull and spine -- chordoma -- could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust. In the largest genomics study of chordoma to date, published today in Nature Communications, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 12, 2017 Category: Cancer & Oncology Source Type: news